This research necessitates continued exploration, potentially revolutionizing future therapeutic strategies
Unlike compounds that act directly on peripheral vascular pathways, PT-141 has been studied for central nervous systemmediated melanocortin activity
The FDA's adverse event database documented more than 990 reports linked to compounded semaglutide and more than 730 linked to compounded tirzepatide as of May 31, 2026, per publicly available FDA safety communications
About the review This review aims to simultaneously promote GLP-1 RA research and enhance users' understanding by synthesizing evidence from recent landmark trials, thereby providing a comprehensive picture of the potential of these drugs as more than just metabolic modulators
6.1 FA overload as a pathogenic catalyst Elevated levels of circulating FAs, derived predominantly from adipose lipolysis, DNL, and excessive dietary intake (238), represent the critical pathogenic drivers of GA
G.CamandolaS